How public programs, insurance rules, and federal financing affect who can get vaccines and how they are paid for
This page explains how vaccines are paid for in the United States. It covers the main public programs, private insurance rules, and federal financing mechanisms that determine who can access vaccines and at what cost. Understanding vaccine funding and coverage helps explain why access varies by age, insurance status, income level, and geography.
This page focuses on the financial and programmatic side of vaccine policy. For how recommendations are made and adopted, see the U.S. Federal Vaccine Policy page. For state-level requirements, see State School Vaccination Requirements.
Under Section 2713 of the Affordable Care Act (codified at 42 U.S.C. section 300gg-13), most private health insurance plans must cover vaccines recommended by the Advisory Committee on Immunization Practices (ACIP) at no cost to the patient when administered by an in-network provider. Under existing law, this coverage obligation is linked to ACIP recommendations once they are adopted into official CDC policy, rather than requiring a new act of Congress for each vaccine.
This mechanism is one of the most significant downstream effects of a federal vaccine recommendation. It means that for most privately insured individuals, a newly recommended vaccine becomes available at no out-of-pocket cost within one plan year of the recommendation.
Following the January 5, 2026 federal schedule changes, major health insurers pledged to continue covering all previously recommended childhood vaccines through at least the end of 2026, regardless of changes to the federal schedule. However, the longer-term coverage picture for 2027 and beyond remains uncertain, particularly for vaccines moved from routine recommendation to shared clinical decision-making or high-risk-only categories.
The March 16, 2026 judicial stay further complicates the coverage baseline. Because the court stayed the January 2026 schedule changes, the pre-January 2026 schedule currently serves as the federal baseline for insurance coverage obligations. For the full account of these developments, see U.S. Federal Vaccine Policy.
This section reflects the situation as of April 2026. Coverage rules may change as legal and administrative proceedings continue.
The Vaccines for Children program is a federally funded entitlement program created in 1993 under the Omnibus Budget Reconciliation Act. It provides vaccines at no cost to eligible children through age 18.
Children are eligible for VFC if they are:
The federal government purchases vaccines directly from manufacturers at a negotiated contract price and distributes them to state and local health departments, which in turn distribute them to enrolled VFC providers (pediatricians, family physicians, public health clinics, and other authorized sites). Providers may charge a small administration fee but cannot deny vaccination to an eligible child based on inability to pay that fee.
VFC is the largest single purchaser of childhood vaccines in the United States. Because it is a mandatory federal entitlement — not a discretionary grant — its funding does not depend on annual congressional appropriation. This makes it a more stable funding source than most other public health programs.
Section 317 of the Public Health Service Act authorizes a federal grant program that funds state and local immunization infrastructure, vaccine purchasing for populations not covered by VFC or private insurance, and outbreak response activities.
In practical terms, Section 317 is a CDC funding stream that helps states run immunization programs, respond to outbreaks, and improve vaccine access for underserved populations.
| Feature | VFC | Section 317 |
|---|---|---|
| Legal status | Mandatory federal entitlement | Discretionary federal grant |
| Funding | Mandatory federal spending | Annual congressional appropriation |
| Eligibility | Uninsured, Medicaid, underinsured, AI/AN children through age 18 | Broader: uninsured adults, outbreak response, infrastructure |
| Vaccine supply | Federal government purchases vaccines directly | Funds flow to states for operations and purchasing |
| Created | 1993 (Omnibus Budget Reconciliation Act) | 1963 (Vaccination Assistance Act) |
Because Section 317 is discretionary, its funding level can fluctuate from year to year depending on congressional appropriation decisions. This makes it more vulnerable to budget pressures than VFC.
Medicare covers certain vaccines for adults aged 65 and older and for certain younger adults with qualifying conditions.
Part B covers vaccines that are directly related to the treatment of an injury or disease, or that pose a direct risk of a condition. The most common Part B-covered vaccines are:
Part B vaccines are generally available at no cost to the beneficiary when administered by a participating provider.
Part D (prescription drug coverage) covers commercially available vaccines not covered under Part B. Since the Inflation Reduction Act of 2022, all Part D-covered vaccines recommended by ACIP are available at no cost to the beneficiary — eliminating a previous gap where Medicare beneficiaries faced cost-sharing for certain adult vaccines.
Medicaid vaccine coverage varies by population:
Children enrolled in Medicaid receive vaccines primarily through the VFC program. Medicaid also covers vaccine administration through the Early and Periodic Screening, Diagnostic, and Treatment (EPSDT) benefit, which requires states to provide all medically necessary services — including immunizations — to Medicaid-eligible children.
Adult Medicaid vaccine coverage changed significantly in 2023. Since October 1, 2023, state Medicaid and CHIP programs must cover FDA-approved adult vaccines recommended by ACIP, and their administration, without cost sharing. This requirement applies broadly — not only to the Medicaid expansion population. In practice, access can still vary because provider participation, pharmacy availability, and administrative processes differ by state and plan.
Even with ACA coverage rules, VFC, Section 317, Medicare, and Medicaid, gaps in vaccine access remain.
Uninsured adults represent the largest coverage gap. While VFC covers children and ACA rules cover the privately insured, uninsured adults must rely on Section 317-funded programs, community health centers, pharmacy-based programs, or manufacturer assistance programs. Availability varies by state, locality, and vaccine type.
Some individuals have insurance that does not cover certain vaccines, covers them only with significant cost-sharing, or does not include in-network providers in accessible locations. The ACA's preventive-services provision addresses most of these situations for non-grandfathered plans, but gaps can still arise for grandfathered plans or plans with limited networks.
Vaccine access is affected by geography. Rural areas may have fewer providers, pharmacies, or public health clinics offering vaccination services. Pharmacy closures and clinic consolidations can reduce access in both rural and urban underserved communities.
Navigating insurance coverage, finding an in-network provider, understanding eligibility for public programs, and managing documentation can be significant barriers — particularly for populations with limited English proficiency, limited health literacy, or limited internet access.